What the doctor orders
Drug cost containment strategies such as mandatory generic substitution and prior authorization rightly dominate discussions about trends in the health benefits industry. But is this preoccupation with cost containment distracting the industry from getting at one of the fundamental causes of poor plan member health and the enormous costs?
- June 1, 2013 September 13, 2019
- 07:00